Abstract BACKGROUND Idiopathic pulmonary fibrosis (IPF) is characterized by an increase in proteolytic enzymes, including matrix metalloproteinases (MMPs) that degrade the extracellular matrix (ECM) and markers of localized inflammation. Protein fragments (neoepitopes) are detectable in the circulation. RESEARCH QUESTION Can short-term trajectories of neoepitopes following initiation of antifibrotic treatment predict therapy-related outcomes including mortality in […]
Differential effects of antifibrotic treatment on outcome prediction via serial CRPM levels in IPF.
September 29, 2025
Chest